BOSTON – The International Society for Vaccines is hosting the 2016 ISV Annual Congress on Oct. 2-4 in Boston. After nine years of collaborating with Elsevier to host these annual conference series, the ISV is the sole organizer of this year’s annual congress, described as the world’s largest scientific conference in the field of vaccines.
Dr. Ann S. De Groot, a founder, chief executive officer and chief strategy officer of Providence-based EpiVax Inc., is one of three co-chairs helping lead the 2016 ISV Annual Congress. For the first time, the ISV Annual Congress will also include Vaccine Renaissance, a regional New England vaccine meeting that is led by De Groot, and the 2016 DNA Vaccine Conference.
For more information or to register, visit www.isvcongress.org/?mc_cid=03410704f5&mc_eid=0b52444ab4.
